{"acquisitions":[],"changes":[],"country":"US","description":"Slate Medicines develops treatments for migraine and other headache disorders, led by SLTE-1009, a subcutaneous anti-PACAP monoclonal antibody. It targets migraine patients underserved by existing therapies such as CGRP inhibitors. By blocking PACAP rather than CGRP, the drug pursues a distinct pathway for harder-to-treat patients.","domain":"slatemedicines.com","employees":null,"founded":2025,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":35.780398,"lng":-78.639099,"location":"Raleigh","multiples":[],"name":"Slate Medicines","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":130000000,"connectionsAmong":[],"currency":"USD","date":"2026-02-24","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"slatemedicines-com-2026-02-24-series-a","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-17","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"slatemedicines-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-17","status":"attributed","url":null},{"fact":"existence","publisher":"slatemedicines.com","retrievedAt":"2026-06-17","status":"self-reported","url":"https://slatemedicines.com"},{"fact":"description","publisher":"slatemedicines.com","retrievedAt":"2026-06-17","status":"self-reported","url":"https://slatemedicines.com"}],"stage":"series-a","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["cdnjs","cloudflare","cloudflare bot management","doubleclick floodlight","google analytics","google tag manager","hsts","http/3","jquery 3.7.1","jquery migrate 3.4.1","kinsta","mysql"],"totalRaisedUsd":130000000,"traction":[],"updatedAt":"2026-06-17","valuations":[]}